Sonata Software Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 29, 2025, 8:07 pm

Competitors of Sonata Software Ltd

All Competitor Stocks of Sonata Software Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:43 am

Below is a detailed analysis of the quarterly data for Sonata Software Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 2,617.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,843.00 Cr. (Dec 2024) to 2,617.00 Cr., marking a decrease of 226.00 Cr..
• For Expenses, as of Mar 2025, the value is 2,445.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,679.00 Cr. (Dec 2024) to 2,445.00 Cr., marking a decrease of 234.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 173.00 Cr.. The value appears strong and on an upward trend. It has increased from 164.00 Cr. (Dec 2024) to 173.00 Cr., marking an increase of 9.00 Cr..
• For OPM %, as of Mar 2025, the value is 7.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Dec 2024) to 7.00%, marking an increase of 1.00%.
• For Other Income, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Dec 2024) to 11.00 Cr., marking a decrease of 10.00 Cr..
• For Interest, as of Mar 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Dec 2024) to 10.00 Cr., marking a decrease of 6.00 Cr..
• For Depreciation, as of Mar 2025, the value is 23.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 32.00 Cr. (Dec 2024) to 23.00 Cr., marking a decrease of 9.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 137.00 Cr. (Dec 2024) to 151.00 Cr., marking an increase of 14.00 Cr..
• For Tax %, as of Mar 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Dec 2024) to 29.00%, marking an increase of 6.00%.
• For Net Profit, as of Mar 2025, the value is 108.00 Cr.. The value appears strong and on an upward trend. It has increased from 105.00 Cr. (Dec 2024) to 108.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.83. The value appears strong and on an upward trend. It has increased from 3.74 (Dec 2024) to 3.83, marking an increase of 0.09.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:12 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:41 pm

Below is a detailed analysis of the balance sheet data for Sonata Software Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 28.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 28.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,678.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,379.00 Cr. (Mar 2024) to 1,678.00 Cr., marking an increase of 299.00 Cr..
• For Borrowings, as of Mar 2025, the value is 516.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 765.00 Cr. (Mar 2024) to 516.00 Cr., marking a decrease of 249.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,533.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,889.00 Cr. (Mar 2024) to 2,533.00 Cr., marking a decrease of 356.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,755.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,061.00 Cr. (Mar 2024) to 4,755.00 Cr., marking a decrease of 306.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,629.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,671.00 Cr. (Mar 2024) to 1,629.00 Cr., marking a decrease of 42.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 249.00 Cr.. The value appears strong and on an upward trend. It has increased from 245.00 Cr. (Mar 2024) to 249.00 Cr., marking an increase of 4.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,877.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,145.00 Cr. (Mar 2024) to 2,877.00 Cr., marking a decrease of 268.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,755.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,061.00 Cr. (Mar 2024) to 4,755.00 Cr., marking a decrease of 306.00 Cr..

Notably, the Reserves (1,678.00 Cr.) exceed the Borrowings (516.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Sonata Software Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has increased from 11.12 (Mar 24) to 15.30, marking an increase of 4.18.
• For Diluted EPS (Rs.), as of Mar 25, the value is 15.28. This value is within the healthy range. It has increased from 11.10 (Mar 24) to 15.28, marking an increase of 4.18.
• For Cash EPS (Rs.), as of Mar 25, the value is 19.67. This value is within the healthy range. It has increased from 15.87 (Mar 24) to 19.67, marking an increase of 3.80.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.45. It has increased from 50.68 (Mar 24) to 61.45, marking an increase of 10.77.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.45. It has increased from 50.68 (Mar 24) to 61.45, marking an increase of 10.77.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 365.90. It has increased from 310.38 (Mar 24) to 365.90, marking an increase of 55.52.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 27.39. This value is within the healthy range. It has decreased from 30.74 (Mar 24) to 27.39, marking a decrease of 3.35.
• For PBIT / Share (Rs.), as of Mar 25, the value is 23.02. This value is within the healthy range. It has decreased from 25.98 (Mar 24) to 23.02, marking a decrease of 2.96.
• For PBT / Share (Rs.), as of Mar 25, the value is 20.66. This value is within the healthy range. It has increased from 16.63 (Mar 24) to 20.66, marking an increase of 4.03.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has increased from 11.12 (Mar 24) to 15.30, marking an increase of 4.18.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.30. This value is within the healthy range. It has increased from 11.12 (Mar 24) to 15.30, marking an increase of 4.18.
• For PBDIT Margin (%), as of Mar 25, the value is 7.48. This value is below the healthy minimum of 10. It has decreased from 9.90 (Mar 24) to 7.48, marking a decrease of 2.42.
• For PBIT Margin (%), as of Mar 25, the value is 6.29. This value is below the healthy minimum of 10. It has decreased from 8.37 (Mar 24) to 6.29, marking a decrease of 2.08.
• For PBT Margin (%), as of Mar 25, the value is 5.64. This value is below the healthy minimum of 10. It has increased from 5.35 (Mar 24) to 5.64, marking an increase of 0.29.
• For Net Profit Margin (%), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 5. It has increased from 3.58 (Mar 24) to 4.18, marking an increase of 0.60.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 8. It has increased from 3.58 (Mar 24) to 4.18, marking an increase of 0.60.
• For Return on Networth / Equity (%), as of Mar 25, the value is 24.89. This value is within the healthy range. It has increased from 21.93 (Mar 24) to 24.89, marking an increase of 2.96.
• For Return on Capital Employeed (%), as of Mar 25, the value is 30.12. This value is within the healthy range. It has decreased from 35.07 (Mar 24) to 30.12, marking a decrease of 4.95.
• For Return On Assets (%), as of Mar 25, the value is 8.93. This value is within the healthy range. It has increased from 5.99 (Mar 24) to 8.93, marking an increase of 2.94.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.30 (Mar 24) to 0.13, marking a decrease of 0.17.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has decreased from 0.47 (Mar 24) to 0.25, marking a decrease of 0.22.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.05. It has increased from 1.81 (Mar 24) to 2.05, marking an increase of 0.24.
• For Current Ratio (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 1.5. It has increased from 0.99 (Mar 24) to 1.04, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 1.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 1.02, marking an increase of 0.06.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 70.83 (Mar 24) to 0.00, marking a decrease of 70.83.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 49.61 (Mar 24) to 0.00, marking a decrease of 49.61.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 29.17 (Mar 24) to 0.00, marking a decrease of 29.17.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 50.39 (Mar 24) to 0.00, marking a decrease of 50.39.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 11.65. This value is within the healthy range. It has increased from 10.03 (Mar 24) to 11.65, marking an increase of 1.62.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.51. This value is within the healthy range. It has increased from 6.68 (Mar 24) to 7.51, marking an increase of 0.83.
• For Enterprise Value (Cr.), as of Mar 25, the value is 9,676.60. It has decreased from 19,868.42 (Mar 24) to 9,676.60, marking a decrease of 10,191.82.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 2.31 (Mar 24) to 0.94, marking a decrease of 1.37.
• For EV / EBITDA (X), as of Mar 25, the value is 12.60. This value is within the healthy range. It has decreased from 23.29 (Mar 24) to 12.60, marking a decrease of 10.69.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 2.33 (Mar 24) to 0.94, marking a decrease of 1.39.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 29.16 (Mar 24) to 0.00, marking a decrease of 29.16.
• For Price / BV (X), as of Mar 25, the value is 5.62. This value exceeds the healthy maximum of 3. It has decreased from 14.26 (Mar 24) to 5.62, marking a decrease of 8.64.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 2.33 (Mar 24) to 0.94, marking a decrease of 1.39.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.04, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness